Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
1993
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
Serum Cyclosporine Concentration and Risk of Acute Graft-versus-Host Disease after Allogeneic Marrow Transplantation
1988
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells
2001
Anthracycline-Induced Cardiomyopathy
2010
Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction
2001
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
Treatment of relapse after allogeneic bone marrow transplantation
1996
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial
1998
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Acute graft-vs-host disease
2001
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience
1998
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: A Phase I/II trial
1995
Cancer immunotherapy via dendritic cells
2012 Standout
Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation
1997
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated Recipients
1996
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
2002
Haematopoietic cell transplantation as immunotherapy
2001 Nature
IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE
1997
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
Acute Myeloid Leukemia and the Position of Autologous Stem Cell Transplantation
2007
Extending Postgrafting Cyclosporine Decreases the Risk of Severe Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell Transplantation
2006
High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
1988
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Autologous bone marrow transplantation in adults with non‐Hodgkin's lymphoma: A southwest oncology group study
1994
Graft-versus-host disease
2009 Standout
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Transplants across human leukocyte antigen barriers
2002
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Hematopoietic Stem-Cell Transplantation
2006 Standout
Allogeneic transplantation of blood stem cells: Coming of age?
2001
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with Mortality
2007
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
1993
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
1999
Clinical Development of Listeria monocytogenes–Based Immunotherapies
2012
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Previous donor pregnancy as a risk factor for acute graft‐versus‐host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation
1990
Cyclosporine
1989 Standout
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells
2000
Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole
2000
Extrathymic positive selection of αβ T-cell precursors in nude mice
1992 StandoutNatureNobel
Anemia of Chronic Disease
2005 Standout
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity
2003
High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.
1994
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
1991
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
2002
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone
2002
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Multicopper Oxidases and Oxygenases
1996 Standout
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]
1996
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
2001
Graft-v-host disease is associated with autoimmune-like thrombocytopenia [see comments]
1989
Cell Surface Antigen and Molecular Targeting in the Treatment of Hematologic Malignancies
2002
Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation
1996
Treatment of Acute Myelogenous Leukemia
1985
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
CD8+minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells
1999
Intravenous Immunoglobulin: Striving for Appropriate Use
2006
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Marrow Transplantation for Thalassemiaa
1985 StandoutNobel
VENO-OCCLUSIVE DISEASE OF THE LIVER
1955
Recipient Tumor Necrosis Factor- and Interleukin-10 Gene Polymorphisms Associate With Early Mortality and Acute Graft-Versus-Host Disease Severity in HLA-Matched Sibling Bone Marrow Transplants
1999
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]
1989
Particulate methane monooxygenase genes in methanotrophs
1995
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
1997
Improved hematopoiesis in anemic Sl/Sld mice by splenectomy and therapeutic transplantation of a hematopoietic microenvironment
1989
Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome
2000
Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience
1985 StandoutNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]
1989
Acquired severe aplastic anemia: progress and perplexity
1984
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment
1990
Phase I Study of 131I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome
1999
Subsets of Patients with Aplastic Anemia Identified by Flow Microfluorometry
1985 StandoutNobel
Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival
1989
Bone Marrow Transplant
1990 Standout
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor
1994
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
1997 StandoutScience
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
2002 StandoutScience
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
1993
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments]
1990
Graft‐versus‐Host Disease
1985
Adult acute myeloid leukaemia: update on treatment
1999
Abnormal Cytogenetics at Date of Morphologic Complete Remission Predicts Short Overall and Disease-Free Survival, and Higher Relapse Rate in Adult Acute Myeloid Leukemia: Results From Cancer and Leukemia Group B Study 8461
2004
Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study
1996
Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells.
1988
Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation
1990
Works of Appelbaum Fr being referenced
Antibody-targeted therapy for myeloid leukemia.
1999
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
1996
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
1991
Marrow transplantation for aplastic anemia.
1984
Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation.
1993
Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.
1992
Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL).
1997
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
1991
Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients.
1990
Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission.
1987
Allogeneic hematopoietic stem cell transplantation for acute leukemia.
1997
Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology.
1991
The pathogenesis of aplastic anemia.
1981
Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
1995
Late complications after marrow transplantation.
1984
Changing trends in marrow transplantation for aplastic anemia.
1992
Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.
1991
Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
1987
Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
1989
Marrow harvesting for autologous marrow transplantation.
1985
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
1997
Molecular diagnosis and clinical decisions in adult acute leukemia.
1999
Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy.
1988
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.
1991
Effects of treatment regimens on post marrow transplant relapse.
1991
Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity.
1990
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.
1987
Hammering away at solid tumors.
1987
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.
1994
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
1996
Use of trimetrexate for the prevention of graft-versus-host disease.
1989
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
1993
Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.
1996
Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
1996